American Journal of Clinical Pathology · 2003 · 371 citations · 37 references
MedicineMolecular GeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaThyroid CancerThyroid CytologyThyroid DisordersLymph Node MetastasesOncogenic Ras MutationsPapillary Thyroid Carcinoma CytologyPapillary Thyroid Carcinoma PathologyPoint MutationsRas SignalingThyroid Cancer GeneticsThyroid Cancer Pathology
The follicular variant (FV) of papillary thyroid carcinoma is characterized by a follicular growth pattern and cytologic features of papillary carcinoma. ret/PTC rearrangements are common in classic papillary thyroid carcinoma (PTC) and PAX8-PPAR gamma and ras mutations in follicular thyroid carcinoma. Their prevalence in FV has not been established. We studied these genetic alterations and clinical-pathologic features in 30 FV cases and compared those with 46 non-FV papillary carcinomas. FV cases revealed 1 ret/PTC rearrangement (3%) and 13 ras mutations (43%). Non-FV cases harbored 13 ret/PTC (28%) (P = .006) and no ras mutations (P = .0002). No PAX8-PPAR gamma was found in either group. FV cases demonstrated a significantly higher prevalence of tumor encapsulation, angiovascular invasion, and poorly differentiated areas and a lower rate of lymph node metastases. These data indicate that the FV of papillary carcinoma has a distinct set of molecular alterations and is characterized by a high frequency of ras point mutations.
37
<i>PAX8-PPAR</i> γ <i>1</i> Fusion in Oncogene Human Thyroid Carcinoma
Todd G. Kroll, Pasha Sarraf, Lorenza Pecciarini et al. · Science · 2000 · 785 citations
Marina N. Nikiforova, Roy A. Lynch, Paul W. Biddinger et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 713 citations · Full text
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
N R Lemoine, E S Mayall, Fiona S. Wyllie et al. · PubMed · 1989 · 420 citations